BRIEF-Resverlogix Exceeds Full Enrollment For The Pivotal Phase 3 Betonmace Clinical Trial By: Reuters: Company News March 19, 2018 at 07:14 AM EDT * RESVERLOGIX EXCEEDS FULL ENROLLMENT FOR THE PIVOTAL PHASE 3 BETONMACE CLINICAL TRIAL Read More >>